Alnylam Pharmaceuticals, Inc.

E. Ohman J:or Asset Management AB ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/12/2026

Shares

4,584

Value ($000)

1,823

Weight

0.0%

2015 Q2 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/12/2026	1,823	0.0%	4,584	12/31/2025
2025 Q3	10/17/2025	2,599	0.1%	5,700	9/30/2025
2025 Q2	7/8/2025	1,859	0.0%	5,700	6/30/2025
2025 Q1	4/11/2025	1,566	0.0%	5,800	3/31/2025
2024 Q4	1/27/2025	1,435	0.0%	6,100	12/31/2024
2024 Q3	10/23/2024	1,485	0.0%	5,400	9/30/2024
2023 Q2	4/5/2024	380	0.0%	2,000	6/30/2023
2023 Q1	4/5/2024	401	0.0%	2,000	3/31/2023
2021 Q4	4/5/2024	1,085	0.0%	6,400	12/31/2021
2021 Q1	4/5/2024	353	0.0%	2,500	3/31/2021
2020 Q4	4/5/2024	325	0.0%	2,500	12/31/2020
2020 Q3	4/5/2024	364	0.0%	2,500	9/30/2020
2020 Q1	4/5/2024	250	0.0%	2,300	3/31/2020
2019 Q4	4/5/2024	369	0.0%	3,200	12/31/2019
2018 Q1	4/5/2024	262	0.0%	2,200	3/31/2018
2017 Q4	4/5/2024	280	0.0%	2,200	12/31/2017
2016 Q3	4/5/2024	108	0.0%	1,600	9/30/2016
2016 Q2	4/5/2024	89	0.0%	1,600	6/30/2016
2016 Q1	4/5/2024	100	0.0%	1,600	3/31/2016
2015 Q4	4/5/2024	151	0.0%	1,600	12/31/2015
2015 Q3	4/5/2024	129	0.0%	1,600	9/30/2015
2015 Q2	4/5/2024	192	0.0%	1,600	6/30/2015